Cleared Traditional

K923221 - KING OF HEARTS SCEPTER

K923221 is an FDA 510(k) clearance for KING OF HEARTS SCEPTER, manufactured by Instromedix, Inc.. The device is a Class 2 Cardiovascular device with product code DPS cleared through the Traditional 510(k) pathway after a 250-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1993
Decision
250d
Days
Class 2
Risk

K923221 is an FDA 510(k) clearance for the KING OF HEARTS SCEPTER. Classified as Electrocardiograph (product code DPS), Class II - Special Controls.

Submitted by Instromedix, Inc. (Hillsboro, US). The FDA issued a Cleared decision on March 8, 1993 after a review of 250 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2340 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Instromedix, Inc. devices

FDA 510(k) Submission Details - K923221

510(k) Number K923221 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 01, 1992
Decision Date March 08, 1993
Days to Decision 250 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
125d slower than avg
Panel avg: 125d · This submission: 250d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DPS Device Classification - Class 2, Special Controls

Product Code DPS Electrocardiograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2340
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DPS Electrocardiograph

All 413
Devices cleared under the same product code (DPS) and FDA review panel - the closest regulatory comparables to K923221.
THE ACTA FORMULA
K922703 · Biosound, Inc. · Apr 1993
MORTARA INSTRUMENT, INC. E-SCRIBE
K930558 · Mortara Instrument, Inc. · Apr 1993
9055 IRCA OPTION FOR SYSTEM ATHENA 9050 NT
K930134 · S & W Medico Teknik · Apr 1993
MORTARA INSTRUMENT ST CENTRAL STATION
K922927 · Mortara Instrument, Inc. · Nov 1992
PERSONAL 120/210 LAPTOP STRESS OPTION
K922291 · Biosound, Inc. · Nov 1992
TYPE 9050/NEO
K912183 · S & W Medico Teknik · Jun 1992